COVID-19接触者追踪的难题:一线机构的经验与思考
本文从Howard Brown Health在芝加哥的实践出发,讨论接触者追踪作为社交网络干预的潜力、利益相关方、部署时机及数字技术影响。作者指出接触者追踪在疫情衰退后期对防止孤立暴发至关重要,并可通过提升检测率和提供社会支持产生间接效益。
要点
- 接触者追踪是利用社交网络结构的干预,可部署检测和社交距离等措施。
- 疫情衰退后期大型活动、学校等重启时,接触者追踪对防止孤立暴发关键。
- 本地追踪可提升检测率并通过提供资源和社会支持应对结构性障碍。
核心结论
- 接触者追踪是诱导性社交网络干预,在疫情衰退后期对防止孤立暴发至关重要。
- 本地接触者追踪可产生间接效益,如提升检测率和通过提供资源应对结构性障碍。
研究设计与样本
- 本文为观点/经验总结类文章,基于Howard Brown Health在芝加哥的实践。
主要发现
- COVID-19正侵入美国最脆弱的网络,现有不平等因社区资源和服务暂停而加剧。
- 接触者追踪部署需考虑潜在影响、利益相关方、部署时机和数字技术的影响。
临床怎么用
- 在疫情衰退后期及大型活动、学校等重启时,应维持本地接触者追踪能力以防孤立暴发。
- 接触者追踪应结合检测提升和提供救生资源与社会支持,以应对结构性障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
COVID-19 contact tracing is an induction social network intervention in which the structure of the social network is leveraged to deploy proven COVID-19 interventions such as testing and social distancing. The Howard Brown Health organization has rapidly expanded to include COVID-19 testing, contact tracing, and linkage to resources since the first cases were identified in Chicago, Illinois. COVID-19 is penetrating the most vulnerable networks in the United States; existing inequities are widening as community resources and organizations have had to place services on hold.Here we address several questions that arise as organizations build capacity for contact tracing, including questions involving the potential impact of contact tracing, stakeholders who could be involved, the timing of contact tracing deployment, and the impact potential for digital technology.Contact tracing is critical at later stages of epidemic decline given the potential for isolated outbreaks as larger events, schools, stadiums, and festivals reopen. Local contact tracing efforts can have other indirect benefits with respect to limiting transmission, such as increasing testing rates and addressing structural barriers through provision of life-saving resources and access to crucial social support.
引用
- Schneider J, Love W, Rusie L, et al. COVID-19 Contact Tracing Conundrums: Insights From the Front Lines. Am J Public Health. 2021. PMID: 33734850. doi:10.2105/AJPH.2021.306200
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。